CONFERENCES

Our Conferences are the best opportunity to enter the ever-expanding world of clinical medicine and fundamental science. Imagine great speakers discussing novel ideas and experience the amazement that comes with every discovery!

Some of our conferences will be Keynote Lectures - special talks held by our most prominent guests.


You are welcome to attend any Conference and Keynote Lecture without prior booking!

 

All conferences will take place on Saturday and will be divided into 2 groups: the morning group and the afternoon group. Please keep in mind that in order to receive your Certificate of Participation, you must attend at least two events (this includes Conferences, Keynote Lectures and Presentations), one in the morning group and one in the afternoon group. In other words, on Saturday, you can go to any Conference, Keynote Lecture or Presentation session you prefer, as long as one is in the morning and the other one in the afternoon.

- OPENING LECTURE -

Aubrey

Aubrey de Grey

Biomedical Gerontology
Chief Science Officer & Co-founder, SENS Research Foundation

Rejuvenation biotechnology: why age may soon cease to mean aging

People are living longer than they used to - no longer because of reductions in child mortality, but because we are postponing the ill-health of old age. But you’ve seen nothing yet: regenerative medicine and other new biomedical technologies will eventually be so comprehensive that people will stay truly youthful however long they live - which means they may mostly live very long indeed. The social and economic consequences of this transition will pervade every aspect of our lives.

For the Opening Ceremony, Aubrey de Grey will discuss both the biology and the sociology of what he considers to be the most momentous advance in the history of civilisation.

Dr Aubrey de Grey is a biomedical gerontologist based in Cambridge, UK and Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a California-based charity dedicated to combating the aging process. He is also Editor-in-Chief of Rejuvenation Research, the world’s highest-impact peer-reviewed journal focused on intervention in aging. He received his BA and PhD from the University of Cambridge in 1985 and 2000 respectively. His research interests encompass the characterisation of all the accumulating and eventually pathogenic molecular and cellular side-effects of metabolism (“damage”) that constitute mammalian aging and the design of interventions to repair and/or obviate that damage. He has developed a possibly comprehensive plan for such repair, termed Strategies for Engineered Negligible Senescence (SENS), which breaks aging down into seven major classes of damage and identifies detailed approaches to addressing each one.

 

- LIST OF KEYNOTE LECTURES -

Judith v.2

Judith E. Brill

Professor of Anesthesiology and Pediatric Critical Care
UCLA David Geffen School of Medicine, USA

15:00 - 16:15, BUENOS AIRES Conference Room

Emergence Delirium in Children: Waking Up is Hard to Do

An abnormal mental state of marked irritation, emergence delirium in children is still considered as a mysterious complication occurring after anesthesia, during the transition from unconsciousness to complete wakefulness. The clinical presentation is dramatic: impaired awareness, confusion, and verbal and physical agitation or hypoactivity. Emergence delirium is not only a unique sight - it’s also dangerous. As it may lead to long-lasting cognitive complications, its occurance, treatment and prevention are of major importance. Dr. Judith E. Brill is a leading pediatric critical care expert and will discuss emergence delirium during her keynote lecture, offering her thoughts on how to cope with this highly stressful situation. Dr. Brill is currently practicing and teaching at University of California, Los Angeles - which has one of the best medical faculties and health care facilities in the world.

adam

Adam Watts

Consultant Elbow, Hand & Upper Limb Surgeon, Wrightington Hospital
Visiting Professor, Manchester University, UK

Getting back in the game: elbow injuries in the elite athlete

Elbow injuries happen - and can shake the careers of legendary professional athletes like Tiger Woods or Serena Williams. These players subject their elbows to high impact and torque, which can result in acute trauma or chronic overuse injuries.
Doctors can help them recover faster and Dr Adam Watts, an orthopaedic surgeon specialised in elbow, hand & upper limb, will explain how. For his Keynote Lecture, he will review the spectrum of elbow pathology encountered in the elite athlete, with an emphasis on early return to play. Dr Adam Watts leads cutting edge elbow research, has lectured all over the world and been widely published.

marvin hp

Marvin E. Ament

Pediatric gastroenterology, hepatology and nutrition
Professor Emeritus at David Geffen School of Medicine UCLA, Los Angeles, USA

Orthotopic Liver Transplantation in Infants and Children

Liver transplantation can be the only solution for end stage organ failure. With the advance of immunosuppression and surgical approaches, this complex procedure can now be safely performed in children - with pediatric patients accounting annually for about 12.5% of liver transplant recipients in the US. But for the best outcome, strict procedures must be followed.

Dr Marvin E. Ament, one of the recognized founders of the pediatric gastroenterology subspecialty in the US, will discuss indications and contraindications in infants and children for Orthotopic Liver Transplantation (OLT), as well as complications of the procedure, and the long-term outcomes, including survival and quality of life following OLT.

Dr Ament established the liver transplantation program at UCLA Medical Center and the small intestinal and multivisceral transplantation program. He developed many of the tools and therapies now accepted as standard practice in pediatric gastroenterology. He is responsible for initially developing a pediatric small bowel biopsy instrument during his early years of training. He pioneered the development of flexible fiber optic upper and lower intestinal endoscopes for infants and children and is recognized as one of the authorities in this field.

Dr Ament was foremost in the recognition of gastroesophageal reflux disease (GERD) in infants and children and was one of the early pioneers in developing the instrumentation for the evaluation of GERD. Dr Ament is unique in that he is both a pediatric and adult gastroenterologist and has continued because of his special training to care for both children and adults throughout his medical career. Dr Ament was the first gastroenterologist in the world to develop a home parenteral nutrition program for infants and children and was primary in establishing such a center at UCLA Medical Center.

Villain

Nicolas Villain

Cognitive & Behavioural Neurology
Professor Dubois Unit, Salpêtrière Hospital, Paris, France

Alzheimer's disease targets brain networks: The perspective from multimodal neuroimaging

Neuroimaging has been a useful tool to describe Alzheimer's disease (AD) for a long time. Beyond its pictorial role, the use of multimodal imaging techniques has also uncovered new evidence about the pathophysiology of the disease. For his Keynote Lecture, Nicolas Villain will explain how network disruption plays a major role in the propagation of AD and how imaging research has become a surprising source of leads for fundamental research.

Nicolas Villain is currently a fellow in Cognitive and Behavioral Neurology in the Prof. Dubois Unit at the Salpêtrière Hospital, Paris, France. He did his training in the French National MD-PhD program (Inserm MD-PhD Program), when he specialised in the multimodal neuroimaging of Alzheimer's disease. He also trained in Melbourne, Australia, for amyloid PET imaging. His medical training as a neurologist took place in Paris, France, with a focus on cognitive & behavioral neurology and movement disorders.

Patrizia

Patrizia Paterlini-Bréchot

Professor of Cell Biology and Oncology
Necker-Enfants Malades Medical Faculty, Paris Descartes University, France

Circulating Rare Cells: An open window on the modern predictive, preventive, and personalized medicine

Routine blood tests provide lots of information - probably just as much as they miss. Take circulating rare cells (CRC), for example. As the name suggests, CRCs are a population of elusive cells which can be extracted from blood samples using specific procedures.

For her Keynote Lecture, Patrizia Paterlini-Bréchot will present a new approach to isolating CRCs, developed by her team. ISET (Isolation by SizE of Tumor/Trophoblastic cells) is a new procedure which eliminates blood cells based on their size, therefore retaining CRCs from blood samples.

Their work on particular subsets of CRCs is especially important, as it has provided innovative results in the field of non-invasive predictive oncology and prenatal diagnosis.

CRC are of different types - professor Paterlini Bréchot and her team have applied ISET to the study of Circulating Tumor Cells (CTC) and of Circulating Fetal Trophoblastic Cells (CFTC).

CTC are clinically relevant as they are the earliest expression of invasive tumors and can be used to predict and prevent the development of metastases. In particular, ISET has allowed to identify CTC in the blood of patients at risk of developing an invasive tumor before the time when the size of the primary invasive tumor has become detectable by imaging.

Professor Paterlini Bréchot and her team have also patented a new and efficient approach to isolate and identify CFTC. They have demonstrated that CFTC circulate in the maternal blood from the 5th week of gestation and have completed a blind clinical trial validating the use of CFTC isolated by ISET for the non-invasive prenatal diagnosis of Cystic Fibrosis and Spinal Muscular Atrophy. Currently, they work to develop a comprehensive approach allowing to achieve in parallel the non-invasive prenatal diagnosis of both monogenic disorders and aneuploidies.

- LIST OF CONFERENCES -

Bumbacea

Dragos Bumbacea

MD, PhD, MPH, FCCP, Associate Professor,
Department of Pneumology,
Carol Davila University of Medicine and Pharmacy

Biologics - The next step in severe asthma treatment

Imagine you suffer from severe asthma, and you’ve tried every treatment available, but nothing has worked. You still can’t breathe. Then a new, different therapy comes along - biologics. This cutting edge treatment attacks the source of the asthma, as opposed to the symptoms, and treats the inflammation at a cellular level. For his conference, Dr Dragos Bumbacea will discuss the promises of this new class of medication.

Dr Bumbăcea is the Head of the Pneumology Department at Elias University Emergency Hospital in Bucharest. He has been trained in different fields in Respiratory Medicine at Carol Davila University Bucharest, Imperial College London and Paris Descartes. He has developed the first Acute Respiratory Care Unit in Romania at Elias University Emergency Hospital specifically designed for the management of patients with acute respiratory failure. His interests include: severe airway diseases, acute and chronic respiratory failure, lung infections in immunocompromised hosts and lung transplantation. He is genuinely interested in medical education, mostly assessment, and is currently a member of the Examination Committee for Adult Respiratory Medicine Examination run by the European Respiratory Society.

gheorghep

Gheorghe Peltecu & Anca Maria Panaitescu

Professor, Department of Gynaecology
Carol Davila University of Medicine and Pharmacy Bucharest, Romania

Assistant Lecturer, Department of Gynaecology
Carol Davila University of Medicine and Pharmacy Bucharest, Romania

Morbidly adherent placenta, a challenge of contemporary obstetrics & Maternal antibodies and fetal defects

Learn more about difficult pregnancies and how experienced gynaecology teams manage these cases. For the first part of the conference, Professor Gheorghe Peltecu will talk about morbidly adherent placenta, a rare condition with potentially life threatening risks - like massive blood loss in the mother and premature birth. For the second part Assistant Lecturer Anca Panaitescu will explain how maternal autoantibodies can cross the placenta and cause fetal damage.

FilipNicolae_ok

Andrei Filip & Miruna Nicolae

MD PhD
AMA Optimex Clinic

 

Surgical approaches for refractive errors

For long-time wearers of glasses or contact lenses, refractive eye surgery has a lot to offer - as it can decrease or even eliminate the dependency on optical aids. The refractive surgery team uses precision laser surgery techniques and specialised lens implants to improve focusing problems. For their conference, doctors Andrei Filip and Miruna Nicolae from AMA Optimex Clinic will present various methods of cornea remodeling and cataract surgery. They will also explain how to select the most appropriate procedure for each patient, taking into account lifestyle factors and vision needs.

Olga

Olga Simionescu

Professor of Dermatology

Carol Davila University of Medicine and Pharmacy Bucharest, Romania

Step forward in the approach of pigmented lesions - an update

Dermoscopy is a modern non-invasive diagnostic tool that plays an important role in skin cancer diagnosis, especially in the case of pigmented lesions. In trained hands, it increases the diagnostic accuracy and can save lives. A trained clinician needs only a few seconds to make an accurate therapeutic decision when analyzing a lesion - but there are numerous multi step diagnostic algorithms that trainee doctors can use as well. For her Conference, professor Olga Simionescu will provide an introduction in dermoscopy and present the basics of dermoscopy in pigmented lesions.

bica&gobej

Dorin Bica & Ionut Gobej

Neurosurgeons, Provita Medical Center, Bucharest, Romania

Keyhole surgery of brain tumours: precision, perspective and points to remember

Some tumors are especially tricky to remove - like those located in the posterior fossa or the suprasellar region - where they come in close contact with crammed vital structures. Fortunately, these tumours have another thing in common. We are talking about a form of treatment that has become the standard in brain tumour neurosurgery - keyhole interventions. Using paired equipment - microscope and neuronavigation - a neurosurgeon can pinpoint the exact location of the tumour and choose the optimal path to remove it. Dr Dorin Bica will speak about his experience in dealing with posterior fossa tumours, exemplifying the symptomatology and various subtypes of tumours, as well as the best trajectory to reach them. And how about applying a modern twist to a classical solution? Dr Ionut Gobej will further present the crucial role of keyhole neurosurgery in removing suprasellar tumors using a pterional approach. Starting from a practical clinical case, he will go through the relevant regional anatomy, diagnostic steps and surgical techniques.

rubin

Rubin Munteanu

Bariatric Surgeon, Head of BariClinic, Monza Hospital, Bucharest, Romania

Treatment of Type 2 Diabetes Mellitus by Laparoscopic Sleeve Gastrectomy

We still don’t fully understand how sleeve gastrectomy improves the evolution of patients with diabetes mellitus, but there are some things we know for sure. The incidence of obesity and type 2 diabetes mellitus has been rising during the last decades and bariatric surgery has proven to be the most effective treatment for obesity. At the moment, laparoscopic sleeve gastrectomy is the most used bariatric procedure. Dr Rubin Munteanu will share his experience of working with patients with diabetes mellitus who underwent sleeve gastrectomy and the encouraging outcomes he has witnessed.

cutmypic

Ana-Gabriela Fruntelata

Senior Lecturer of Cardiology, Carol Davila University of Medicine and Pharmacy
Head of Cardiology Department, Monza Clinical Hospital

Living with heart failure - a global health challenge
(In memoriam Prof. Mihai Gheorghiade)

Heart failure is the final stage of all heart diseases. As medicine progresses, people don't die of myocardial infarction, valve disease or arrhythmias anymore, but they develop longlife heart failure as they become older. Heart failure has a higher mortality rate than many forms of cancer and comes with enormous costs for all societies and healthcare systems, as well as for patients and physicians. Real progress has been made in the last decades in the treatment and management of heart failure. Advances in imaging - like cardiac MR or hybrid imaging - has lead to better diagnosis and care. Cardiac resynchronisation therapy has been a life-saving step for numerous patients with heart failure and left bundle branch block. Progress of ablation techniques for arrhythmias, left and right ventricular assist devices and even development of simple new molecules like sacubitril/valsartan or the new anticoagulants have been proven not only to improve quality of life, but also to prolong life of these patients. Given all these, we can confidently say that we are providing significantly better care for a hardly curable disease; however, heart failure remains a major challenge. A challenge not only for cardiologists and cardiac surgeons, but for physicians in all specialties.